Dun & Bradstreet Corp (DNB) 140.12 $DNB Dun & Bradstreet

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dun & Bradstreet Corp (DNB) 140.12 $DNB

Dun & Bradstreet (DNB) is in Overbought Territory: What's Next?
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 9:58AM CDT
Dun & Bradstreet Corporation (DNB) has moved higher as of late, but there could definitely be trouble on the horizon for this company
DNB: 140.12 (-0.61)

Dun & Bradstreet Corp (DNB) Catches Eye: Stock Jumps 7.6%
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 7:40AM CDT
The Dun & Bradstreet Corporation (DNB) saw its shares rise almost 8% on the day.
DNB: 140.12 (-0.61), ADBE: 97.08 (+0.41)

Dun & Bradstreet (DNB) Beats on Q2 Earnings & Revenues
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:40AM CDT
Dun & Bradstreet Corp. (DNB) reported second-quarter 2016 results wherein adjusted earnings of $1.37 per share and revenues of $398.8 million easily beat the Zacks Consensus Estimate.
NLSN: 53.16 (-0.19), DNB: 140.12 (-0.61), CRM: 80.96 (+0.55), FDS: 172.75 (+0.55)

Dun & Bradstreet Reports Second Quarter 2016 Results; Announces Transactions to Partner Latin America and Benelux
BusinessWire - Mon Aug 01, 3:30PM CDT
--Updates Full Year 2016 Guidance
DNB: 140.12 (-0.61)

Dun & Bradstreet Collaborates with Non-Profit FinTech Sandbox to Help Promote Innovation in the Financial Industry
PR Newswire - Wed Jul 13, 9:34AM CDT
FinTech Sandbox startups looking to develop or test new products and enhancements for the financial technology sector will now have access to Dun & Bradstreet's global commercial data on businesses large and small, public and private.
DNB: 140.12 (-0.61)

Dun & Bradstreet Shares Up 31.5% Since SmarTrend's Buy Recommendation (DNB)
Comtex SmarTrend(R) - Mon Jun 20, 1:04PM CDT
SmarTrend identified an Uptrend for Dun & Bradstreet (NYSENB) on March 1st, 2016 at $97.23. In approximately 4 months, Dun & Bradstreet has returned 31.50% as of today's recent price of $127.86.
DNB: 140.12 (-0.61)

Despite Improved Access to Capital, Small Businesses Still Heavily Dependent on Personal Resources, According to Private Capital Access Study
PR Newswire - Mon Jun 20, 8:00AM CDT
The ability of small businesses to access needed capital has steadily risen in the past four years, according to the second quarter results from the Private Capital Access (PCA) Index by Dun & Bradstreet and Pepperdine University Graziadio School of Business and Management. Despite this, the survey found that small businesses' access to traditional bank loans, while increasing, still lags behind that of middle market companies, forcing small businesses to rely on personal assets and personal credit.
DNB: 140.12 (-0.61)

Dun & Bradstreet Has Returned 29.7% Since SmarTrend Recommendation (DNB)
Comtex SmarTrend(R) - Fri Jun 10, 1:09PM CDT
SmarTrend identified an Uptrend for Dun & Bradstreet (NYSENB) on March 1st, 2016 at $97.23. In approximately 3 months, Dun & Bradstreet has returned 29.73% as of today's recent price of $126.14.
DNB: 140.12 (-0.61)

Verisk's 3E Company Offers Round-the-Clock OSHA Services
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 10:18AM CDT
3E Company, a division of Verisk Analytics, Inc. (VRSK), recently announced the launch of its new employee and workplace safety stewardship capabilities.
TRU: 32.25 (+0.11), VRSK: 80.93 (+1.50), DNB: 140.12 (-0.61), VVI: 35.51 (-0.14)

Dun & Bradstreet Announces Strategic Partnership with The Latino Coalition
PR Newswire - Thu Jun 09, 8:00AM CDT
Dun & Bradstreet and The Latino Coalition (TLC) today announced a partnership aimed at bringing Dun & Bradstreet's research, services and tools to thousands of The Latino Coalition's members. The partnership will kick off at the Annual Latino Coalition Small Business Summit on June 15, 2016.
DNB: 140.12 (-0.61)

Qvidian Accelerates Worldwide Growth
BusinessWire - Tue Jun 07, 9:43AM CDT
Qvidian, the innovator in sales execution solutions, today announced an 83 percent increase in sales volume currently in 2016 compared to the prior year period. This growth is most notably reflected in the Company's Proposal Automation and RFP Management technology solution. Recent new customer wins across US and Europe include Samsung Electronics America, Inc. (SEA), Dun and Bradstreet (NYSENB), Panduit, Home Savings, TMG, Corporate Fitness Works, Fuel Education, Sterling and Hitachi Solutions Europe.
ARMK: 35.51 (-0.01), C: 43.95 (+0.06), DNB: 140.12 (-0.61), CA: 33.83 (+0.20), RST: 8.16 (+0.47)

Middle Market Companies Are Fueling Economic Growth, According to New Research from American Express and Dun & Bradstreet
BusinessWire - Wed Jun 01, 8:30AM CDT
Despite comprising only 1% of the total number of commercially active firms(1) in the country, middle market companies have led national job growth over the past five years, employing nearly 53 million workers - more than double the number employed by this segment in 2011. Middle market firms are also contributing $9.3 trillion to the U.S. economy, according to the Middle Market Power Index from American Express (NYSE: AXP) and Dun & Bradstreet (NYSE: DNB).
AXP: 63.78 (-0.05), DNB: 140.12 (-0.61)

28.5% Return Seen to Date on SmarTrend Dun & Bradstreet Call (DNB)
Comtex SmarTrend(R) - Thu May 26, 1:09PM CDT
SmarTrend identified an Uptrend for Dun & Bradstreet (NYSENB) on March 1st, 2016 at $97.23. In approximately 3 months, Dun & Bradstreet has returned 28.49% as of today's recent price of $124.93.
DNB: 140.12 (-0.61)

5 Ways Modern Finance Teams Can Deliver Growth
PR Newswire - Thu May 26, 11:46AM CDT
It's no coincidence that the Chief Financial Officer's (CFO's) expanding role as a strategic business leader has coincided with the expanding role of digital technologies and data-driven decision making within the corporation. In companies that have successfully navigated the economic turbulence of recent years, CFOs have emerged as key leaders by helping their companies leverage mounting stores of data to address competitive challenges, such as managing risk and working capital, sustaining growth and charting a long-term path forward towards growth.
DNB: 140.12 (-0.61)

Businesses Using NetSuite Now Have Direct Access to Dun & Bradstreet's Proprietary Commercial Data and Analytics
PR Newswire - Mon May 23, 12:08PM CDT
NetSuite Inc.'s (NYSE: N) customers will have the ability to directly access commercial data and analytics from Dun & Bradstreet (NYSE: DNB) from within NetSuite's industry leading cloud-based business management suite to help better manage risks and improve efficiencies across their entire operations. The combination of the world's most deployed cloud Enterprise Resource Planning (ERP) solution from NetSuite and the world's largest commercial database from Dun & Bradstreet, provides NetSuite customers with a single unified view of their customer, vendor and partner relationships and automated credit management in a single system of record.
DNB: 140.12 (-0.61), N: 108.55 (+0.02)

Dun & Bradstreet (DNB): Moving Average Crossover Alert
Zacks Equity Research - Zacks Investment Research - Fri May 13, 10:12AM CDT
Are you a technical investor? If so, it may be time to consider The Dun & Bradstreet Corporation (DNB) for your portfolio
DNB: 140.12 (-0.61)

Dun & Bradstreet Announces Platinum Sponsorship of NetSuite SuiteWorld 2016
PR Newswire - Thu May 12, 12:00PM CDT
Dun & Bradstreet (NYSE: DNB) today announced its Platinum Sponsorship of SuiteWorld 2016, NetSuite's annual user conference for its customers, partners, media and industry analysts, being held May 16-19 in San Jose, Calif. NetSuite's SuiteWorld 2016 is the leading Cloud ERP conference, with more than 8,000 expected attendees coming together to get inspired, network, celebrate cloud success, gain industry knowledge and share insights and best practices.
DNB: 140.12 (-0.61)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading